Clinical Pathology
About Tumor Marker and Hormonal LevelTumor Marker and Hormonal Level
Tumor marker tests detect substances linked to cancers such as Prostate cancer and Ovarian cancer. They assist in diagnosis, monitoring treatment, and detecting recurrence. These markers are not used alone but with other tests. They provide important clinical insights. Tumor markers support cancer management. Hormone level tests measure hormones to assess endocrine gland function. They help diagnose conditions like Hypothyroidism and Diabetes mellitus. These tests guide treatment and monitor therapy. They are important for metabolic and reproductive health. Hormone balance is vital for the body.
AFP is a tumor marker normally produced during fetal development. In adults, elevated levels are associated with certain cancers, especially liver cancer (hepatocellular carcinoma) and some germ cell tumors. It is also used to monitor treatment response and detect recurrence.
CA-125 is a protein commonly elevated in ovarian cancer. It is mainly used to monitor treatment and disease progression rather than for screening, as levels can also rise in benign conditions like menstruation, pregnancy, or pelvic inflammation.
CA 15-3 is a tumor marker primarily associated with breast cancer. It is used to monitor response to treatment and detect recurrence, particularly in advanced cases, rather than for early diagnosis.
CA 19-9 is a marker often elevated in pancreatic cancer and other gastrointestinal cancers, such as colorectal or gastric cancer. It is mainly used for monitoring disease progression and treatment effectiveness.
FPSA refers to the unbound form of prostate-specific antigen in the blood. It is measured along with total PSA to help differentiate between benign prostate conditions and prostate cancer, as lower free PSA levels are more suggestive of malignancy.
TPSA measures the total amount of prostate-specific antigen (both free and bound forms) in the blood. It is widely used as a screening and monitoring tool for prostate cancer, although elevated levels can also occur in benign prostate enlargement or inflammation.
Beta-hCG is a hormone normally produced during pregnancy, but elevated levels in non-pregnant individuals may indicate certain tumors, especially germ cell tumors and trophoblastic diseases. It is used for diagnosis and monitoring of these cancers.
Thyroglobulin (TG) is a protein produced by thyroid cells and serves as a tumor marker to monitor patients with differentiated thyroid cancers after treatment. Anti-thyroglobulin antibodies (Anti-TG) are immune proteins often present in conditions like Hashimoto's thyroiditis and can interfere with TG measurement. Therefore, both TG and Anti-TG are tested together to accurately assess disease status and detect recurrence.
Follicle-stimulating hormone (FSH) and luteinizing hormone (LH) are pituitary hormones that regulate reproductive function, including ovulation in females and sperm production in males. Their levels help evaluate infertility, menstrual disorders, and conditions like polycystic ovary syndrome. Abnormal ratios or levels can indicate dysfunction of the pituitary, ovaries, or testes.
Prolactin is a hormone responsible for milk production and is produced by the pituitary gland. Elevated levels may cause infertility, irregular menstruation, or galactorrhea and are often associated with prolactinoma. Measuring prolactin helps assess pituitary function and related endocrine disorders.
Metabolic hormonal testing includes evaluating hormones like insulin, cortisol, and thyroid hormones to assess the body’s metabolic and endocrine balance. These tests help diagnose disorders such as diabetes mellitus and hypothyroidism. They are useful for identifying hormonal imbalances affecting energy, weight, and overall metabolism.
"Health is the most important thing you have in life!"
Contact us now to schedule an appointment.